Skip to main content

Table 1 Baseline characteristics

From: Prognostic impact of KIHON checklist score in elderly patients with hemodialysis initiation

Factor

All patients (N = 24)

Lower KCL (N = 17)

Higher KCL (N = 7)

p value

Demographics

Age (years old)

76 [70, 78]

76 [69,78]

77 [71,80]

0.63

65—69 y.o (number, %)

4 (16.0)

5 (29.4)

2 (28.6)

 

70—74 y.o (number, %)

3 (12.0)

2 (11.8)

1 (14.3)

 

Over 75 y.o (number, %)

18 (72.0)

10 (58.8)

4 (57.1)

 

Men (number, %)

20 (83.3)

13 (76.5)

7 (100)

0.28

Current smoke (number, %)

4 (17.4)

1 (6.2)

3 (42.9)

0.067

Body height (cm)

164 [159, 169]

164 [159, 167]

164 [156, 172]

0.78

Body weight (kg)

59.1 [52.6, 65.4]

56 [52.7, 65.0]

61.6 [55.6, 69.8]

0.59

Body mass index (kg/m2)

22.0 [20.6, 24.4]

20.9 [20.4, 23.3]

23 [21.8, 25.8]

0.39

Systolic blood pressure (mmHg)

139 [119, 149]

142 [122, 152]

129 [116, 139]

0.22

Diastolic blood pressure (mmHg)

65 [58, 78]

68 [57, 85]

62 [58, 65]

0.28

Diagnosis

Glomerulosclerosis (number, %)

12 (50.0)

9 (52.9)

3 (42.9)

0.13

Diabetic nephropathy (number, %)

6 (25.0)

5 (29.4)

1 (14.3)

Chronic glomerulonephritis (number, %)

2 (8.3)

0 (0.0)

2 (28.6)

Other (number, %)

4 (17.4)

3 (18.6)

1 (14.3)

Comorbidity

Diabetes mellitus (number, %)

9 (37.5)

7 (41.2)

2 (28.6)

0.67

History of cardiovascular disease (number, %)

16 (66.7)

12 (70.6)

4 (57.1)

0.65

History of bone fracture (number, %)

3 (12.5)

1 (5.9)

2 (28.6)

0.19

History of hospitalization for infectious disease (number, %)

5 (20.8)

2 (11.8)

3 (42.9)

0.13

History of malignancy (number, %)

5 (20.8)

4 (23.5)

1 (14.3)

1

Malignancy (number, %)

3 (12.5)

3 (17.6)

0 (0.0)

0.53

Charlson comorbidity index (point)

8 [7, 9]

8 [7, 8]

8 [6, 10]

0.72

Medication

Angiotensin II receptor blocker (number, %)

13 (54.2)

9 (52.9)

4 (57.1)

1

Statin (number, %)

9 (37.5)

6 (35.3)

3 (42.9)

1

Insulin (number, %)

3 (12.5)

3 (17.6)

0 (0.0)

0.53

Vitamin D receptor agonist (number, %)

2 (8.3)

0 (0.0)

2 (28.6)

0.070

Laboratory

Hemoglobin (g/dL)

9.5 [8.5, 9.9]

9.6 [8.4, 9.9]

9.4 [9.3, 9.9]

0.63

Total protein (g/dL)

5.9 [5.8, 6.7]

6 [5.9, 6.7]

5.8 [4.9, 6.7]

0.35

Albumin (g/dL)

3.2 [3.0, 3.5]

3.3 [3.0, 3.6]

3 [2.5, 3.2]

0.13

Serum urea nitrogen (mg/dL)

72.5 [53.9, 79.6]

73.0 [50.4, 81.6]

72.0 [59.7, 77.5]

0.78

eGFR (mL/min/1.73 m2)

7.5 [5.5, 8.4]

7.5 [5.2, 8.4]

7.5 [7.0, 8.3]

0.57

C-reactive protein (mg/dL)

0.33 [0.15, 0.57]

0.25 [0.09, 0.38]

0.64 [0.40, 0.84]

0.045*

Triglyceride (mg/dL)

129 [79, 152]

121 [67, 145]

150 [94, 179]

0.33

Total cholesterol (mg/dL)

160 [146, 188]

6 [5.9, 6.7]

5.8 [4.9, 6.7]

0.35

  1. Continuous variables are presented as median and interquartile. Categorical variables are presented as number and percentage. *p < 0.05 by Mann–Whitney U test for continuous variables and Fischer’s exact test for categorical variables
  2. Charlson comorbidity index is calculated from age, diabetes with diabetic complications, congestive heart failure, peripheral vascular disease, chronic pulmonary disease, mild and severe liver disease, hemiplegia, renal disease, leukemia, lymphoma, metastatic tumor and acquired immunodeficiency syndrome
  3. y.o, years old; eGFR, estimated glomerular filtration rate; KCL, KIHON checklist